CoChat

Rapid benefit of intravenous pulse loading of clomipramine in obsessive- compulsive disorder

Open access
· 1997 · American Journal of Psychiatry
Cited by 102

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The authors conducted a randomized, double-blind, placebo-controlled trial of intravenous versus oral pulse loading of clomipramine in patients with obsessive-compulsive disorder to test two hypotheses: 1) intravenous pulse loading will cause greater immediate improvement than oral pulse loading and 2) patients who respond to pulse loading will continue to improve during 8 weeks of oral clomipramine treatment. METHOD: Fifteen patients with DSM-III-R obsessive-compulsive disorder of at least 1 year's duration and baseline Yale-Brown Obsessive Compulsive Scale scores of 17 or higher were enrolled in the study. Yale-Brown scale ratings were made 4.5 days after double-blind oral or intravenous pulse loading of clomipramine, and patients were then given 150 mg/day of oral clomipramine with increases of 25 mg every 4 days to 250 mg/day as tolerated or, in two cases, other selective serotonin reuptake inhibitors (SSRIs). RESULTS: The first hypothesis was confirmed: 4.5 days after the second pulse-loaded dose, six of seven patients given intravenous clomipramine but only one of eight given oral medication responded to the drug. After 8 weeks of oral clomipramine, the results partially supported the second hypothesis: four of six patients who had responded to intravenous clomipramine continued their improvement, but those who had responded to pulse loading did not improve statistically significantly more than those who had not. CONCLUSIONS: Intravenous pulse loading of clomipramine may be a valuable new treatment for obsessive-compulsive disorder, particularly for patients who have failed oral treatment trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/ajp.154.3.396

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 31

  1. 10.1001/archpsyc.1989.01810110048007 · DOI · Paper page
  2. 10.1001/archpsyc.1991.01810320054008 · DOI · Paper page
  3. 10.1097/00004714-199604000-00004 · DOI · Paper page
  4. Goodman WK, 1992, J Clin Psychiatry, 53, 29
  5. 10.1001/archpsyc.1995.03950130053006 · DOI · Paper page
  6. Wheadon DE, 1993, American College of Neuropsychopharmacology 32nd Annual Meeting. Nashville, Tenn, ACN, 193
  7. Jenike MA, 1994, J Clin Psychiatry, 55, 11
  8. 10.1016/S0033-3182(71)71497-2 · DOI
  9. 10.1177/030006057300100523 · DOI
  10. Rack PH, 1977, J Int Med Res, 5, 81, 10.1177/030006057700502S16 · doi:10.1177/030006057700502s16
  11. 10.1177/030006057300100506 · doi:10.1177/030006057300100506
  12. Faravelli C, 1987, Psychopharmacol Bull, 23, 459
  13. 10.1177/030006057300100525 · doi:10.1177/030006057300100525
  14. 10.1177/070674378402900211 · DOI
  15. Warneke LB, 1985, J Clin Psychiatry, 46, 100
  16. 10.1177/070674378903400902 · DOI
  17. 10.1176/jnp.4.1.70 · DOI · Paper page
  18. Koran LM, 1994, J Clin Psychopharmacol, 14, 216
  19. Sallee FR, 1989, Psychopharmacol Bull, 25, 114
  20. Spitzer RL, 1990, Gibbon M
  21. 10.1001/archpsyc.1989.01810010031005 · DOI · Paper page
  22. 10.1210/jcem-68-3-632 · DOI · Paper page
  23. Carson S, 1991, American College of Neuropsychopharmacology 30th Annual Meeting. Nashville, Tenn, ACN, 226
  24. 10.1111/j.2044-8260.1967.tb00530.x · DOI · Paper page
  25. Mavissakalian MR, 1990, J Clin Psychopharmacology (Berl), 10, 261
  26. 10.1016/0022-3956(95)00042-9 · DOI
  27. 10.1111/j.2042-7158.1977.tb11255.x · doi:10.1111/j.2042-7158.1977.tb11255.x
  28. 10.1001/archpsyc.1991.01810300052007 · DOI
  29. 10.1172/JCI115086 · DOI · Paper page
  30. 10.1016/0028-3908(94)90073-6 · DOI
  31. Potter WZ, 1980, Psychopharmacol Bull, 16, 32

Cited by

Metadata

Venue
American Journal of Psychiatry
Published
1997-03-01
Volume
154
Issue
3
Pages
396-401
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W1534208980
Cited by
102
References
1
FWCI
9.63
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.